Table. Baseline Demographic Characteristics of Participants Included in Subset Analysis.
Characteristic | Participants, No. (%) | ||
---|---|---|---|
Estradiol + placebo gel (n = 45) | Moisturizer + placebo tablet (n = 48) | Dual placebo (n = 51) | |
Age at screening, mean (SD), y | 61 (4) | 60 (4) | 61 (5) |
Race | |||
Black | 5 (11) | 1 (2) | 0 (0) |
White | 37 (82) | 43 (90) | 49 (96) |
Othera | 3 (7) | 4 (8) | 2 (4) |
MBS | |||
Pain with sex | 19 (42) | 32 (67) | 28 (55) |
Dryness | 11 (24) | 8 (17) | 14 (27) |
Itch, burn, or irritation | 15 (33) | 8 (17) | 9 (18) |
Vaginal maturation index, <5% superficial cells | 37 (82) | 37 (77) | 40 (78) |
pH, mean (SD) | 6.8 (1.0) | 6.6 (1.1) | 6.9 (0.9) |
Subsequent MBS symptom improvement ≥2 points | 24 (53) | 21 (44) | 25 (49) |
Abbreviation: MBS, most bothersome symptom.
Other race includes 2 American Indian individuals, 6 Asian or Pacific Islander individuals, and 1 unknown individual with unknown race.